Me NaPhos MB Hyo 1 (Method Pharmaceuticals)


Welcome to the PulseAid listing for the Me NaPhos MB Hyo 1 drug offered from Method Pharmaceuticals. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Method Pharmaceuticals
NON-PROPRIETARY NAME: Urinary Antiseptic Antispasmodic
SUBSTANCE NAME: METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; METHYLENE BLUE ANHYDROUS; HYOSCYAMINE SULFATE ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2015-12-01
END MARKETING DATE: 0000-00-00


Me NaPhos MB Hyo 1 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMe NaPhos MB Hyo 1 from Method Pharmaceuticals
LABELER NAME: Method Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 81.6; 40.8; 10.8; .12(mg/1; mg/1; mg/1; mg/1)
START MARKETING DATE: 2015-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58657-454_2ae628e7-3b34-6a9a-e054-00144ff8d46c
PRODUCT NDC: 58657-454
APPLICATION NUMBER:

Other METHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; METHYLENE BLUE ANHYDROUS; HYOSCYAMINE SULFATE ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Method PharmaceuticalsMe NaPhos MB Hyo 1